Gene Knock-in Service
Knock-in (KI) involves the precise insertion of specific genes or sequences into defined genomic sites, allowing the introduction of reporter genes or therapeutic genes under natural gene regulation. This is essential for studying gene function, tracking expression, and developing disease models. Creative Biolabs offers high-quality CRISPR knock-in cell line services with reliable, precise gene integration, helping global clients create stable, customized models to advance their research.
Overview of Gene Knock-in Technology
Gene knock-in refers to the targeted insertion of exogenous or engineered DNA sequences into a specific genomic location. Unlike random integration methods, knock-in technology is designed to place the sequence of interest at a defined locus, allowing researchers to preserve endogenous regulatory control, reduce positional variation, and generate more reproducible cell models.
Figure 1. Gene knock-in. Blue box indicates a gene locus to which a target gene is integrated. Red and yellow boxes are neighboring genes, and purple boxes indicate the heterologous gene to be knocked-in.1
In CRISPR-mediated knock-in, a programmable nuclease such as Cas9 is guided to a selected genomic site by a guide RNA. The nuclease creates a site-specific DNA break, after which the cell repairs the break through endogenous DNA repair pathways. When an appropriate donor template is supplied, researchers can guide the repair process to introduce the desired sequence at the target locus. Depending on the experimental goal, the donor template may contain short homology arms, long homology arms, selection markers, reporter genes, epitope tags, loxP sites, polyadenylation signals, or other functional elements.
Quick Comparison: KO vs. KI Technologies
| Feature | Gene Knock-out (KO) | Gene Knock-in (KI) |
|---|---|---|
| Primary Mechanism | Gene disruption, silencing, or deletion. | Targeted insertion, replacement, or tagging. |
| Cellular Repair Pathway | NHEJ (Non-Homologous End Joining) | HDR (Homology-Directed Repair) |
| Natural Frequency | High (Highly efficient naturally) | Very Low (<1% without optimization) |
| Technical Complexity | Moderate (Requires precise gRNA) | Extremely High (Requires gRNA, optimized donor templates, and advanced delivery systems) |
| Trending Applications | Target screening, allogeneic cell therapy, loss-of-function assays. | Safe-harbor integration, endogenous reporter tagging, gene correction therapies. |
Why Gene Knock-in Matters for Modern Biomedical Research?
Traditional overexpression systems are useful in many settings, but they may produce non-physiological expression levels, artificial protein localization, altered stoichiometry, or unexpected cellular stress. In contrast, endogenous gene knock-in allows the inserted tag or sequence to be controlled by the native promoter and regulatory elements. This helps researchers observe gene or protein behavior in a more natural biological environment.
- Stable Integration Reduces Experimental Variation
Transient transfection and random integration approaches often produce heterogeneous expression, variable copy numbers, and inconsistent results between experiments. Gene knock-in enables stable integration at a defined locus, supporting long-term experiments and reproducible downstream assays. Once validated, a knock-in clone can be expanded, banked, and used across multiple experimental campaigns.
- Isogenic Models Improve Disease Mechanism Studies
Gene knock-in can be used to introduce disease-associated variants, pathogenic mutations, or clinically relevant sequence changes into a defined cellular background. Compared with unrelated patient-derived cell lines, isogenic knock-in models allow researchers to compare edited and parental cells with reduced genetic background noise.
Introduction of Gene Knock-in Service
Gene KI is a genetic engineering technique that precisely inserts specific genes or sequences into designated genomic locations. Unlike knockout, which removes gene function, knock-in introduces new elements—such as reporter genes, fluorescent tags, or therapeutic genes—while preserving the overall integrity of the genome. This approach is widely used to study gene expression, protein localization, and regulatory mechanisms in a controlled cellular environment. By enabling stable and accurate gene integration, KI cell models play a critical role in disease modeling, drug discovery, and functional genomics, making them an essential tool in modern biological research.
How Gene Knock-in Service Can Assist Your Project
Creative Biolabs is dedicated to delivering high-quality knock-in (KI) single-cell clones with precise gene integration, stable expression, and long-term reliability. Our advanced CRISPR-based KI technology ensures accurate insertion while maintaining the natural gene regulation within cells, making these models ideal for studying gene function, protein expression, and disease mechanisms. Each clone undergoes rigorous quality control, including PCR sequencing and mycoplasma testing, to verify successful gene integration, eliminate contamination risks, and ensure consistent, reproducible results. Additionally, multiple clients have confirmed the effectiveness of our KI cell lines through independent functional assays, demonstrating their reliability in real-world applications.
Service Details
| Cell Types | Various cell types, including tumor, conventional, stem, primary, and immortalized cell lines. |
|---|---|
| Service Options | Targeted knock-in of fluorescent proteins / Targeted knock-in of tag proteins / Targeted knock-in at specific sites of a gene of interest / Gene point mutations |
| Delivery Standard | One monoclonal stable cell line (2 cryovials, 1×106 cells per vial) |
| Turnaround | As fast as 8 weeks |
Each project begins with an evaluation of the target locus, insert sequence, desired editing outcome, and downstream application. Based on this information, Creative Biolabs develops a practical editing plan designed to maximize the likelihood of obtaining correctly edited clones while maintaining cell viability and genetic stability.
Gene Knock-in Strategy Design
Creative Biolabs provides comprehensive design support to improve project feasibility and reduce avoidable experimental delays.
-
Target Locus Evaluation
Our team evaluates the target gene or genomic locus according to the desired insertion site, transcript structure, coding sequence, exon organization, protein domain arrangement, regulatory elements, and potential functional impact. -
Guide RNA Design and Screening
Creative Biolabs designs guide RNAs near the intended insertion site and evaluates candidates based on predicted activity, proximity to the target site, genomic specificity, and compatibility with donor template design. -
Donor Template Design
Creative Biolabs designs donor templates with appropriate homology arms and functional sequence architecture. For protein tagging projects, we ensure that the inserted sequence maintains the correct reading frame and includes a suitable linker design when needed. -
Selection and Screening Strategy
Creative Biolabs can incorporate antibiotic selection, fluorescence-based enrichment, PCR-based screening, sequencing confirmation, or other approaches, depending on the project design. Our team develops a screening plan that balances efficiency, accuracy, and cell viability.
Workflow of Gene Knock-in Service
Figure. 2 Workflow of our gene knock-in service.
Advantages of Gene Knock-in Service
- High Success Rate & Stability - Efficiently integrates sequences up to 2000 bp with high precision, ensuring stable and reproducible results.
- Precise Disease Modeling - Introduces disease-related genes to create reliable models, overcoming the limitations of scarce patient samples.
- Broad Cell Type Adaptability - Works with various cell types, including stem and primary cells, supporting diverse research applications.
- Strict Quality Control - Validates knock-in accuracy and stability through PCR, sequencing, and other rigorous testing methods to guarantee reliable results.
- Affordable & Reliable Support - Provides cost-effective solutions with dedicated after-sales assistance for seamless project execution.
Our Quality Control and Validation Options
Creative Biolabs offers multiple validation options depending on project requirements:
- Junction PCR to confirm correct insertion
- Sanger sequencing to verify inserted sequence and junctions
- Genotyping of candidate clones
- Copy-number or allele assessment when applicable
- Expression detection by RT-PCR or qPCR when needed
- Protein detection by Western blot or immunostaining
- Fluorescence detection for fluorescent tag or reporter models
- Flow cytometry for surface markers or fluorescent reporters
- Reporter activity assay when applicable
- Mycoplasma testing
- Cell morphology and growth evaluation
- Cell expansion and cryopreservation
Clients may select standard validation or request expanded validation depending on downstream application.
Common Gene Knock-in Formats
| Knock-in Format | Typical Purpose | Example Applications |
|---|---|---|
| Small tag knock-in | Detect endogenous protein | HA, Myc, His, V5 tag insertion |
| Fluorescent protein knock-in | Visualize protein localization | GFP, EGFP, fluorescent reporter models |
| Reporter gene knock-in | Monitor gene or pathway activity | Luciferase or fluorescent reporter cell lines |
| Disease mutation knock-in | Build isogenic disease model | Pathogenic variant introduction, mutation mechanism studies |
| Safe-harbor knock-in | Stable transgene expression | Long-term expression cell lines, assay platforms |
| Conditional knock-in | Controlled gene activation or expression | Cre-loxP-based or inducible models |
| Selection cassette knock-in | Facilitate clone recovery | Antibiotic resistance or fluorescence selection |
| Functional motif insertion | Study protein regulation | Degron, localization signal, interaction motif insertion |
Case-Oriented Service Examples
Example 1: Fluorescent Tag Knock-in for Protein Localization
A client needs to study the intracellular localization of a signaling protein under endogenous expression conditions. Creative Biolabs designs a C-terminal fluorescent tag knock-in strategy, constructs the donor template, performs CRISPR editing, isolates single-cell clones, and validates correct insertion by PCR and sequencing. The final clone supports live-cell imaging and protein trafficking studies.
Example 2: Reporter Knock-in for Pathway Screening
A research team wants to monitor activation of a disease-relevant pathway in response to compound treatment. Creative Biolabs designs a reporter knock-in model under endogenous regulatory control, screens clones for correct insertion, and validates reporter responsiveness. The final cell line can be used for assay development and compound screening.
Example 3: Disease Variant Knock-in for Mechanism Study
A client aims to investigate a pathogenic mutation in an isogenic cellular background. Creative Biolabs introduces the disease-associated sequence change into the target locus, screens edited clones, and confirms the genotype. The resulting model helps compare mutant and parental cells in functional assays.
Frequently Asked Questions (FAQ)
Q: What is the primary technical difference between Gene Knock-out (KO) and Gene Knock-in (KI)?
A: Gene KO relies on the Non-Homologous End Joining (NHEJ) pathway, which naturally occurs at a high frequency following a DNA double-strand break, leading to frameshifts. Gene KI, however, relies on Homology-Directed Repair (HDR), a highly complex pathway that occurs at very low frequencies (often <1% naturally). Achieving successful KI requires sophisticated donor template design, advanced viral delivery systems, and cell-cycle synchronization to artificially boost HDR rates.
Q: How do you assess and mitigate off-target effects?
A: We mitigate risks upfront by utilizing proprietary, highly stringent algorithms for genome-wide sgRNA screening. For clinically sensitive projects, we deploy high-fidelity Cas9 variants. Post-editing, we offer targeted deep sequencing or Whole Genome Sequencing (WGS) to provide an authoritative, data-driven safety profile of your clonal line.
Q: My project involves notoriously hard-to-transfect primary immune cells. Can you handle this?
A: Absolutely. For recalcitrant cell types, we abandon standard lipofection or harsh electroporation protocols. Instead, we engineer highly tropic recombinant AAV or Lentiviral vectors customized for your specific cell type. This viral-mediated approach delivers an overwhelming efficiency advantage in primary cell engineering.
Q: What types of sequences can be inserted through gene knock-in?
A: Gene knock-in can be used to insert short tags, fluorescent proteins, reporter genes, selection markers, disease-associated variants, regulatory elements, functional motifs, or research transgenes. The feasibility depends on the insert size, target locus, cell type, and donor design. Creative Biolabs evaluates each project individually and recommends a suitable knock-in strategy.
Q: Can Creative Biolabs help design the knock-in strategy if I only have a target gene?
A: Yes. If you provide the target gene, desired application, and cell type, Creative Biolabs can help evaluate possible insertion sites, guide RNA candidates, donor template design, tag position, screening strategy, and validation plan. Early design support is especially helpful for projects involving endogenous tagging, reporter insertion, or disease mutation modeling.
Start Your Gene Knock-in Project with Creative Biolabs
By providing customized, contamination-free KI cell models, Creative Biolabs help researchers obtain more precise, reproducible data, accelerating discoveries in biomedical research and drug development. Contact us to explore how our KI cell line services can enhance your research projects.
Reference
- Nakashima N, Miyazaki K. Bacterial cellular engineering by genome editing and gene silencing. International journal of molecular sciences, 2014, 15(2): 2773-2793. https://doi.org/10.3390/ijms15022773 Distributed under Open Access license CC BY 4.0, without modification.
